VCRO’s professional team assisted our client’s small molecule drug product in submitting a clinical trial application for Alzheimer’s disease to the US FDA.
In June 2024, we received FDA approval to proceed with its Phase I clinical trial, successfully helping our client smoothly enter the Phase I clinical trial stage.
To date, VCRO has accumulated experience in 51 projects assisting clients in applying for US FDA IND. We are familiar with FDA interactions, keep abreast of current regulatory requirements, and provide clients with comprehensive strategic planning based on our rich and solid experience, guiding you through every stage of the clinical trial process.
